Caitlin Baptiste

Caitlin Baptiste

Auto-generated profile, based on publicly available information

Caitlin Baptiste

Columbia University Irving Medical Center, New York, NY

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2022 in Prenatal Diagnosis
Verified
Journal Article
Closed access
CBCaitlin Baptiste
Caitlin Baptiste
RMRhiannon Mellis
Rhiannon Mellis
VAVimla Aggarwal
Vimla Aggarwal
JLJenny Lord
Jenny Lord
RERuth Eberhardt
Ruth Eberhardt
LCLyn Chitty
Lyn Chitty

6 December 2023 in Prenatal Diagnosis
Verified
Journal Article
Open access
GBGillian V. Blayney
Gillian V. Blayney
ELEoghan Laffan
Eoghan Laffan
PJPreethi A. Jacob
Preethi A. Jacob
CBCaitlin D. Baptiste
Caitlin D. Baptiste
HGHeinz Gabriel
Heinz Gabriel
FMFionnuala Mone
Fionnuala Mone
Objectives: Determine the incremental diagnostic yield of prenatal exome sequencing (pES) over chromosome microarray (CMA) or G‐banding karyotype in fetuses with central nervous system (CNS) abnormalities.Methods: Data were collected via electronic searches from January 2010 to April 2022 in MEDLINE, Cochrane, Web of Science and EMBASE. The NHS England prenatal exome cohort was also included. Incremental yield was calculated as a pooled value using a random‐effects model.Results: Thirty studies were included (n = 1583 cases). The incremental yield with pES for any CNS anomaly was 32% [95%CI 27%–36%; I2 = 72%]. Subgroup analysis revealed apparent incremental yields in; (a) isolated CNS anomalies; 27% [95%CI 19%–34%; I2 = 74%]; (b) single CNS anomaly; 16% [95% CI 10%–23%; I2 = 41%]; (c) more than one CNS anomaly; 31% [95% Cl 21%–40%; I2 = 56%]; and (d) the anatomical subtype with the most optimal yield was Type 1 malformation of cortical development, related to abnormal cell proliferation or apoptosis, incorporating microcephalies, megalencephalies and dysplasia; 40% (22%–57%; I2 = 68%). The commonest syndromes in isolated cases were Lissencephaly 3 and X‐linked hydrocephalus.Conclusions: Prenatal exome sequencing provides a high incremental diagnostic yield in fetuses with CNS abnormalities with optimal yields in cases with multiple CNS anomalies, particularly those affecting the midline, posterior fossa and cortex.

1 February 2021 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
CBCaitlin Baptiste
Caitlin Baptiste
NBNoelle Breslin
Noelle Breslin
ACAlexander Chong
Alexander Chong
FVFrancesa Vallese
Francesa Vallese
BCBrianna K. Costabile
Brianna K. Costabile
CGCynthia Gyamfi-Bannerman
Cynthia Gyamfi-Bannerman
Universal testing has shown that a proportion of asymptomatic pregnant women test positive for COVID-19 on RT-PCR. This study aimed to assess the seroprevalence of COVID-19.

1 August 2020 in American Journal of Obstetrics & Gynecology MFM
Verified
Journal Article
Open access
NBNoelle Breslin
Noelle Breslin
CBCaitlin Baptiste
Caitlin Baptiste
CGCynthia Gyamfi-Bannerman
Cynthia Gyamfi-Bannerman
RMRussell Miller
Russell Miller

11 August 2026 in Pregnancy
Verified
Journal Article
Open access
TKThomas P. Kishkovich
Thomas P. Kishkovich
GTGabriela F. Tessler
Gabriela F. Tessler
MAMeghan Angley
Meghan Angley
YZYijia Zhang
Yijia Zhang
TIThomas A. Imahiyerobo
Thomas A. Imahiyerobo
RWRonald Wapner
Ronald Wapner
Introduction: Cleft lip and palate (CLP) are common congenital disruptions of the orofacial cleft and are associated with numerous genetic conditions. This study examines prenatal findings, clinical outcomes, and genetic findings among prenatally diagnosed CLP, with a focus on the yield of next‐generation sequencing (NGS). Methods: This was a retrospective cohort study of prenatally diagnosed CLP presenting to a tertiary‐care referral center between 2017 and 2024. Inclusion required pre‐/postnatal diagnostic genetic testing. Imaging findings, genetic diagnoses, and delivery and postnatal outcomes were compared between those with isolated CLP (iCLP) and CLP with additional anomalies (CLP+). t ‐tests, Wilcoxon rank‐sum test, chi‐square test, or Fisher's exact test were used as appropriate. Results: A total of 57 pregnancies met inclusion criteria: 19 (33.3%) iCLP and 38 (66.7%) CLP+. Among CLP+, the most common additional prenatally detected anomalies were central nervous system (55.3%) and cardiac (52.6%). Groups had similar rates of termination and live birth (26.0% and 68.0% overall, respectively). Neonatal intensive care unit (NICU) admission was frequent at 70.6%, and similar between groups (50.0% iCLP vs. 81.8% CLP+, p = 0.11). Across the cohort, 21 (36.8%) pregnancies had reported findings from genetic testing, with 16 (28.1% of total cohort, 76.2% of those with genetic findings) possessing findings explanatory of CLP. CLP+ pregnancies were more likely to have explanatory genetic findings (36.8% vs. 10.5%, p = 0.04). Eleven of 16 (68.8%) likely causative findings were detected via karyotype/CMA. Among 29 patients with NGS, five (17.2%) had likely causative variants not detected by karyotype/CMA. NGS increased overall pathogenic diagnostic yield from 19.3% to 28.1% and diagnosed additional clinically relevant findings in three cases. Conclusion: Postnatal outcomes were overall similar between groups, with high rates of NICU admission. While CLP+ had higher rates of genetic findings, all CLP had risk of genetic disorders. In cases with non‐causative karyotype/CMA, sequencing revealed explanatory diagnostic variants in one in six cases, increasing diagnostic yield by nearly 10%. We advocate for comprehensive prenatal imaging and diagnostic genetic evaluation, including sequencing, for all prenatal CLP cases.

1 February 2021 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
NBNoelle Breslin
Noelle Breslin
DBDana Becker
Dana Becker
CBCaitlin Baptiste
Caitlin Baptiste
JGJessica L. Giordano
Jessica L. Giordano
RWRonald Wapner
Ronald Wapner
RMRussell S. Miller
Russell S. Miller
To determine the prevalence of pathogenic/potentially pathogenic genetic findings in isolated and non-isolated fetal omphalocele.